SCHEMBL8061602

SCHEMBL8061602

C/C(=C\c1ccc(Cl)cc1)C(=O)Nc1ccccc1C(=O)O

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 4/20 0.82
TRPM8 Q7Z2W7 2/20 0.82
TRPA1 O75762 4/20 0.60
NPC1 O15118 5/20 0.54
RAB9A P51151 5/20 0.54
CTDSP1 Q9GZU7 1/20 0.53
SMN1; SMN2 Q16637 3/20 0.51
SUCNR1 Q9BXA5 1/20 0.47
KMT2A Q03164 5/20 0.47
MEN1 O00255 4/20 0.47
KDM4E B2RXH2 4/20 0.46
ALDH1A1 P00352 3/20 0.46
HPGD P15428 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
MAPT P10636 3/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
POLB P06746 1/20 0.46
PKM P14618 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
TRPM2 O94759 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8061608 1.00 DHODH (0.82) DHODHTRPM8TRPA1NPC1RAB9A
SCHEMBL8065734 0.90 DHODH (1.00) DHODHTRPM8TRPA1NPC1RAB9A
SCHEMBL8065731 0.90 DHODH (1.00) DHODHTRPM8TRPA1NPC1RAB9A
SCHEMBL21470188 0.88 DHODH (0.75) DHODHTRPM8TRPA1NPC1RAB9A
SCHEMBL8141637 0.88 DHODH (0.84) DHODHTRPM8TRPA1NPC1RAB9A
SCHEMBL21470195 0.88 DHODH (0.84) DHODHTRPM8TRPA1NPC1RAB9A
SCHEMBL8141640 0.88 DHODH (0.84) DHODHTRPM8TRPA1NPC1RAB9A
SCHEMBL8061707 0.88 DHODH (0.84) DHODHTRPM8TRPA1NPC1RAB9A
SCHEMBL8061709 0.88 DHODH (0.84) DHODHTRPM8TRPA1NPC1RAB9A
SCHEMBL8049318 0.86 DHODH (0.82) DHODHTRPM8TRPA1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6127392-A A MUSCLE RELAXANT FOR TREATMENT OF DISORDERS ASSOCIATED WITH SMOOTH MUSCLE CONTRACTION VIA POTASSIUM CHANNEL AND CHLORIDE CHANNEL MODULATION; INOTROPIC AGENT AMERICAN HOME PRODUCTS CORPORATION (US) 2000-10-03 US disclosed
US-6046239-A USED IN THE TREATMENT OF DISORDERS ASSOCIATED WITH SMOOTH MUSCLE CONTRACTION, VIA POTASSIUM CHANNEL AND CHLORIDE CHANNEL MODULATION SUCH AS URINARY INCONTINENCE, ASTHMA, ANGINA, PREMATURE LABOR, CONGESTIVE HEART FAILURE AMERICAN HOME PRODUCTS CORPORATION (US) 2000-04-04 US disclosed